BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27717503)

  • 1. BTLA-expressing CD11c antigen presenting cells in patients with active tuberculosis exhibit low capacity to stimulate T cell proliferation.
    Wang WD; Gao YC; Lu YB; Zhang JA; Liu GB; Kong B; Xiang WY; Dai YC; Yu SY; Jia Y; Fu XX; Yi LL; Zheng BY; Chen ZW; Zhong J; Xu JF
    Cell Immunol; 2017 Jan; 311():28-35. PubMed ID: 27717503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The number of peripheral blood CD11c+ antigen presenting cells increases and their function strengthens in the patients with active pulmonary tuberculosis].
    Lu Y; Wang W; Liu G; Zhang J; Gao Y; Jia Y; Yi L; Xu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):378-81. PubMed ID: 26927560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3
    Zhang JA; Lu YB; Wang WD; Liu GB; Chen C; Shen L; Luo HL; Xu H; Peng Y; Luo H; Huang GX; Wu DD; Zheng BY; Yi LL; Chen ZW; Xu JF
    Front Immunol; 2020; 11():518. PubMed ID: 32296431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of BTLA and B7-H4 on the surface of myeloid dendritic cells has a negative regulatory effect on their anti-tuberculosis immunity activity in pleural tuberculosis patients.
    Cai X; Ge N; Rong R; Lu Y; Zhang J; Xu J
    Tuberculosis (Edinb); 2019 Dec; 119():101877. PubMed ID: 31677529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation.
    Stephen TL; Niemeyer M; Tzianabos AO; Kroenke M; Kasper DL; Kalka-Moll WM
    Infect Immun; 2005 Apr; 73(4):2184-9. PubMed ID: 15784561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.
    Ebert EC; Mehta V; Das KM
    Clin Exp Immunol; 2005 Apr; 140(1):157-65. PubMed ID: 15762887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of antigen-presenting and costimulatory molecules by lung cells from tuberculosis patients.
    Flores-Batista VC; Boechat N; Lago PM; Lazzarini LC; Pessanha LR; Almeida AS; Mafort TT; Kritski AL; Ho JL; Lapa-e-Silva JR
    Braz J Med Biol Res; 2007 Dec; 40(12):1671-9. PubMed ID: 17713660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis.
    Ng SC; Plamondon S; Al-Hassi HO; English N; Gellatly N; Kamm MA; Knight SC; Stagg AJ
    Clin Exp Immunol; 2009 Nov; 158(2):205-18. PubMed ID: 19737136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
    Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
    Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis.
    Zeng JC; Lin DZ; Yi LL; Liu GB; Zhang H; Wang WD; Zhang JA; Wu XJ; Xiang WY; Kong B; Chen ZW; Wang CY; Xu JF
    Am J Transl Res; 2014; 6(5):494-506. PubMed ID: 25360214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of BSA antigen sensitization during the acute phase of influenza A viral infection on CD11c+ pulmonary antigen presenting cells.
    Sato F; Nakazawa M; Yamamiya S; Tamura C; Hongo N; Hotta C; Minami M
    Allergol Int; 2009 Sep; 58(3):445-54. PubMed ID: 19628980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to Immunotherapy.
    Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Morisaki T; Goto M; Iwama M; Akaike T; Hasumi K
    Anticancer Res; 2016 Feb; 36(2):673-6. PubMed ID: 26851023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting capacity of alveolar macrophages and monocytes in pulmonary tuberculosis.
    Ina Y; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Eur Respir J; 1991 Jan; 4(1):88-93. PubMed ID: 2026242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex.
    Axelsson S; Magnuson A; Lange A; Alshamari A; Hörnquist EH; Hultgren O
    BMC Immunol; 2020 Mar; 21(1):14. PubMed ID: 32197584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of B and T lymphocyte attenuator on CD4
    Shen X; Zhang J; Tang P; Song H; Liu X; Huang Z; Zhang X; Wang X; Wu M
    Indian J Pathol Microbiol; 2019; 62(2):232-238. PubMed ID: 30971546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.